血管紧张素转化酶2
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
缺氧(环境)
受体
冠状病毒
胃肠病学
医学
内科学
食管
免疫学
生物
病毒学
化学
疾病
传染病(医学专业)
有机化学
氧气
作者
Leandro Jimenez,Ana Campos Codo,Vanderson de Souza Sampaio,Antônio Edson Rocha Oliveira,Lucas Kaoru Kobo Ferreira,Gustavo Gastão Davanzo,Lauar de Brito Monteiro,João Victor Virgílio-da-Silva,Mayla Gabriela Silva Borba,Gabriela Fabiano de Souza,Nathália Zini,Flora de Andrade Gandolfi,Stéfanie Primon Muraro,José Luiz Proença‐Módena,Fernando Val,Gisely Cardoso de Melo,Wuelton Marcelo Monteiro,Maurício Lacerda Nogueira,Marcus Lacerda,Pedro M. Moraes‐Vieira
标识
DOI:10.3389/fmed.2021.637885
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect a broad range of human tissues by using the host receptor angiotensin-converting enzyme 2 (ACE2). Individuals with comorbidities associated with severe COVID-19 display higher levels of ACE2 in the lungs compared to those without comorbidities, and conditions such as cell stress, elevated glucose levels and hypoxia may also increase the expression of ACE2 . Here, we showed that patients with Barrett's esophagus (BE) have a higher expression of ACE2 in BE tissues compared to normal squamous esophagus, and that the lower pH associated with BE may drive this increase in expression. Human primary monocytes cultured in reduced pH displayed increased ACE2 expression and higher viral load upon SARS-CoV-2 infection. We also showed in two independent cohorts of 1,357 COVID-19 patients that previous use of proton pump inhibitors is associated with 2- to 3-fold higher risk of death compared to those not using the drugs. Our work suggests that pH has a great influence on SARS-CoV-2 Infection and COVID-19 severity.
科研通智能强力驱动
Strongly Powered by AbleSci AI